Zafirlukast is a leukotriene receptor antagonist used to treat asthma [1]. It works by blocking the action of leukotrienes, which are chemicals that cause inflammation and airway constriction in asthma [2]. By inhibiting leukotrienes, zafirlukast helps to reduce asthma symptoms such as wheezing, coughing, and shortness of breath [2].
How long does it take for Zafirlukast to work?
The full effects of zafirlukast may not be noticeable for several weeks. While some patients may experience relief from asthma symptoms relatively quickly, it is important to continue taking the medication as prescribed to achieve its maximum benefit [3].
What are the side effects of Zafirlukast?
Common side effects of zafirlukast can include headache, nausea, diarrhea, and abdominal pain [4]. Less common but more serious side effects have been reported, including liver problems and a rare condition called Churg-Strauss syndrome, which can affect the lungs and other organs [5]. Patients experiencing any unusual or severe symptoms should consult their healthcare provider [5].
When does the patent for Zafirlukast expire?
Information regarding specific patent expiry dates for zafirlukast is available on DrugPatentWatch.com [6]. Patent expirations can influence the availability of generic versions of the medication.
Can generic versions of Zafirlukast be made available?
Once the patents protecting zafirlukast expire, and regulatory approvals are obtained, generic versions of the drug can be manufactured and marketed. The availability of generic zafirlukast can lead to lower treatment costs for patients [6].
How does Zafirlukast compare to other asthma medications?
Zafirlukast belongs to a class of drugs called leukotriene modifiers, which work differently from inhaled corticosteroids, the primary treatment for persistent asthma. While inhaled corticosteroids reduce inflammation directly in the airways, zafirlukast targets a specific inflammatory pathway involving leukotrienes [2]. The choice of medication depends on individual patient needs, asthma severity, and response to treatment.
Where can I find more information on Zafirlukast patents and exclusivity?
DrugPatentWatch.com provides comprehensive data on drug patents, including those for zafirlukast, and can offer insights into market exclusivity timelines [6].
Sources:
[1] https://www.nhs.uk/medicines/zafirlukast/
[2] https://www.lung.org/lung-health-diseases/lung-disease-lookup/asthma/treatment-options-for-asthma/leukotriene-modifiers
[3] https://www.nhs.uk/medicines/zafirlukast/when-to-take-zafirlukast/
[4] https://www.nhs.uk/medicines/zafirlukast/side-effects-of-zafirlukast/
[5] https://www.lung.org/lung-health-diseases/lung-disease-lookup/churg-strauss-syndrome
[6] https://drugpatentwatch.com/